The Israeli national population program of genetic carrier screening for reproductive purposes

被引:53
作者
Zlotogora, Joel [1 ,2 ,3 ,4 ]
Grotto, Itamar [2 ,3 ,5 ]
Kaliner, Ehud [2 ,3 ]
Gamzu, Ronni [3 ]
机构
[1] Dept Community Genet, Jerusalem, Israel
[2] Publ Hlth Serv, Jerusalem, Israel
[3] Minist Hlth, Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[5] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
关键词
Arabs; Druze; Jews; Israel; population genetic screening; TAY-SACHS-DISEASE; IMPACT;
D O I
10.1038/gim.2015.55
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: The Israeli population genetic screening program for reproductive purposes, launched in January 2013, includes all known, nationally frequent severe diseases (carrier frequency 1:60 and/or disease frequency 1 in 15,000 live births). The carrier screening program is free of charge and offers testing for cystic fibrosis, fragile X-syndrome, and spinal muscular atrophy for nearly the entire population, according to disease frequency among the different groups within the population. We report the results of the first year of the program. Methods: Data on the tests performed over a 12-month period were collected from laboratories nationwide. Results: More than 62,000 individuals were examined. The carrier frequency was within the expected range for most of the diseases. The few exceptions included lower carrier rates for cystic fibrosis among Muslim Arabs (1: 236) and Druze (1: 1,021) and Niemann-Pick type A among Muslim Arabs in a delineated region of Israel (1: 229). Conclusion: The national population genetic carrier screening is aimed toward providing couples with knowledge of the existing options for the prevention of serious genetic conditions when it is relevant for them. It is still too early to determine whether this aim has been achieved.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 17 条
  • [1] [Anonymous], EUR J HUM GENET
  • [2] Large-scale population screening for spinal muscular atrophy: Clinical implications
    Ben-Shachar, Shay
    Orr-Urtreger, Avi
    Bardugo, Eyal
    Shomrat, Ruth
    Yaron, Yuval
    [J]. GENETICS IN MEDICINE, 2011, 13 (02) : 110 - 114
  • [3] Preconceptional and prenatal screening for fragile X syndrome: Experience with 40 000 tests
    Berkenstadt, Michal
    Ries-Levavi, Liat
    Cuckle, Howard
    Peleg, Leah
    Barkai, Gad
    [J]. PRENATAL DIAGNOSIS, 2007, 27 (11) : 991 - 994
  • [4] Ekstein J, 2001, ADV GENET, V44, P297
  • [5] Gluck Iris, 1998, Human Mutation, V12, P136
  • [6] The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities
    Hoffman, Jodi D.
    Park, Jessica J.
    Schreiber-Agus, Nicole
    Kornreich, Ruth
    Tanner, Alice K.
    Keiles, Steven
    Friedman, Kenneth J.
    Heim, Ruth A.
    [J]. PRENATAL DIAGNOSIS, 2014, 34 (12) : 1161 - 1167
  • [7] Kaback MM, 2001, ADV GENET, V44, P253
  • [8] Koren A, 2002, HAREFUAH, V141, P1210
  • [9] Koren Ariel, 2002, Harefuah, V141, P938
  • [10] An empirical estimate of carrier frequencies for 400+causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals
    Lazarin, Gabriel A.
    Haque, Imran S.
    Nazareth, Shivani
    Iori, Kevin
    Patterson, A. Scott
    Jacobson, Jessica L.
    Marshall, John R.
    Seltzer, William K.
    Patrizio, Pasquale
    Evans, Eric A.
    Srinivasan, Balaji S.
    [J]. GENETICS IN MEDICINE, 2013, 15 (03) : 178 - 186